A micellar cisplatin prodrug simultaneously eliminates both cancer cells and cancer stem cells in lung cancer
Author:
Affiliation:
1. School of Life Sciences
2. University of Science & Technology of China
3. Hefei
4. P.R. China
Abstract
Cancer stem cells and bulk cancer cells can be simultaneously targeted when using nanomedicine.
Funder
National Natural Science Foundation of China
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering
Link
http://pubs.rsc.org/en/content/articlepdf/2017/BM/C7BM00278E
Reference42 articles.
1. Global cancer statistics
2. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
3. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
4. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
5. Polymeric biomaterials for the delivery of platinum-based anticancer drugs
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunogenic dead cells engineered by the sequential treatment of ultraviolet irradiation/cryo-shocking for lung-targeting delivery and tumor vaccination;Biomaterials Science;2024
2. A convergent fabrication of 1-aminopyridine-capped gold nanomaterials and reduced graphene oxide nanocomposites for ovarian cancer cells;Gold Bulletin;2023-11-27
3. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022;European Journal of Medicinal Chemistry;2022-12
4. Synergic Fabrication of Cabazitaxel-Loaded Dendritic Supramolecular Iron Nanomaterials for the Delivery of Tumor Regression and Magnetic Drug Targeting (MDT) in the Melanoma Tumor Model;Journal of Cluster Science;2022-11-29
5. Precise engineering of cholesterol-loaded chitosan micelles as a promising nanocarrier system for co-delivery drug-siRNA for the treatment of gastric cancer therapy;Process Biochemistry;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3